Several legislative and regulatory actions have been discussed or signed into law to combat COVID-19. The Academy’s Ad Hoc Task Force on COVID-19 is reviewing policies and guidelines that will shape how dermatologists provide care and conduct business. The Academy will continue to update members as new information is available.
Looking for details on the financial support Congress and government agencies have made available? Visit the Academy's financial support for dermatologists page.
Economic stimulus packages
Phase One: H.R. 6074 – Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
On March 6, President Donald Trump signed into law supplemental funding bills to provide $8.3 billion to address the coronavirus outbreak, which includes funding for research and development of vaccines, therapeutics, diagnostics, health care workers’ training and community health centers.
Phase Two: H.R. 6201 – Families First Coronavirus Response Act
On March 18, 2020, President Donald Trump signed H.R. 6201 into all, which includes waivers and modifications of Federal nutrition program, employment-related protections and benefits, health programs and insurance coverage requirements, and related tax credits.
Phase Three: On March 27, President Trump signed a groundbreaking $2 trillion economic stimulus and COVID-19 relief package called the Coronavirus Aid, Relief and Economic Security (CARES) Act. The new law includes relief for small businesses, temporarily suspends the Medicare sequester, and further relaxes Medicare’s telehealth provisions. Additionally, the new law outlines individual and family taxpayer relief, Indian Health Services funding, preparedness and response support, and CDC and NIH grants, and addresses drug shortages and OTC drug reform as it relates to sunscreen.
Interim COVID-19 Funding: On April 24, President Trump signed legislation to provide an additional $484 billion to aid small businesses and hospitals as well as bolster testing efforts. Highlights include:
$321 billion increase to the Payroll Protection Program through the Small Business Administration (SBA)
$310 billion for direct loans
$11 billion to cover fees associated with program
$10 billion for the Economic Injury Disaster Loan program
$75 billion for the Department of Health and Human Services to send to providers
$25 billion for national comprehensive testing strategy
The AADA continues to monitor any adjustments or next steps made by Congress.
Additional COVID-19 government action resources
All content solely developed by the American Academy of Dermatology